have a new treatment option that combines olopatadine hydrochloride and mometasone furoate in the form of a nasal spray. Ryaltris (Hikma Pharmaceuticals PLC and Glenmark Pharmaceuticals Ltd ...

Naloxone comes as both a nasal spray and injection. Sponsor Message It's not immediately clear how the new drug will be used differently compared to naloxone, and some experts see potential ...

The Food and Drug Administration has approved a new medication to treat migraine headaches. Zavzpret (zavegepant) is a nasal spray that can help provide pain relief in as little as 15 minutes in ...

The US Food and Drug Administration approved a new nasal spray as a rapid treatment for migraine pain in adults. The nasal spray zavegepant, sold as Zavzpret, may relieve pain and other bothersome ...

Joyce Lee for The New York Times Supported by By Caroline ... The resulting repeated need for nasal spray isn’t technically considered an addiction, said Dr. Jonathan Bernstein, an allergist ...

The FDA has approved a nasal spray, called neffy ... Overall, patients and allergy experts alike seem optimistic about a new, small device that can be carried easily and has a good shelf life.